Hims & Hers Health annual return on equity
2021
2022
2023
2024
2025
Hims & Hers Health Return on Equity (ROE) Growth & History (HIMS)
Hims & Hers Health's return on equity was 25.23% for fiscal 2025.
View full Hims & Hers Health company overviewHims & Hers Health annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 25.23% | −5.49 pp |
| 2024 | 2024-12-31 | 30.71% | +37.89 pp |
| 2023 | 2023-12-31 | −7.18% | +13.14 pp |
| 2022 | 2022-12-31 | −20.32% | +94.36 pp |
| 2021 | 2021-12-31 | −114.69% | — |
Hims & Hers Health quarterly return on equity
Q3.19
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −22.41% | −30.05 pp |
| Q1 2026 | 2026-03-31 | −18.66% | −28.31 pp |
| Q4 2025 | 2025-12-31 | 3.67% | −2.01 pp |
| Q3 2025 | 2025-09-30 | 2.76% | −16.09 pp |
| Q2 2025 | 2025-06-30 | 7.65% | +3.88 pp |
| Q1 2025 | 2025-03-31 | 9.65% | +6.41 pp |
| Q4 2024 | 2024-12-31 | 5.68% | +5.31 pp |
| Q3 2024 | 2024-09-30 | 18.85% | +21.18 pp |
| Q2 2024 | 2024-06-30 | 3.76% | +6.03 pp |
| Q1 2024 | 2024-03-31 | 3.23% | +6.46 pp |
| Q4 2023 | 2023-12-31 | 0.37% | +3.87 pp |
| Q3 2023 | 2023-09-30 | −2.33% | +3.65 pp |
| Q2 2023 | 2023-06-30 | −2.26% | +3.82 pp |
| Q1 2023 | 2023-03-31 | −3.22% | +1.68 pp |
| Q4 2022 | 2022-12-31 | −3.50% | +5.53 pp |
| Q3 2022 | 2022-09-30 | −5.98% | −1.06 pp |
| Q2 2022 | 2022-06-30 | −6.09% | −2.96 pp |
| Q1 2022 | 2022-03-31 | −4.91% | +65.71 pp |
| Q4 2021 | 2021-12-31 | −9.04% | — |
| Q3 2021 | 2021-09-30 | −4.92% | — |
| Q2 2021 | 2021-06-30 | −3.13% | — |
| Q1 2021 | 2021-03-31 | −70.61% | — |
| Q3 2019 | 2019-09-30 | 17.41% | — |
Hims & Hers Health return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Hims & Hers Health's return on equity increased from −114.69% to 25.23%, a change of +139.91 percentage points. The latest reported quarter, Q2 2026, shows −22.41%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Hims & Hers Health source filings ↗